or
Bookmark and Share
Transdermal device for the delivery of flurbiprofen
 
   
Document Number
US Patent 5702720
Issued Date
December 30, 1997
Link
Inventors
Map
Abstract
A transdermal drag delivery device involving an acrylate or methacrylate based copolymer, a skin penetration enhancer, a polyvinylpyrrolidone polymer, and a therapeutically effective amount of flurbiprofen.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
18
Comments:
no comments yet
Published
December 30, 1997
Application Number
08/577,482
Filed
December 22, 1995
US Classification
424/448   424/449
Int'l Classification
A61K   9/70   (20060101)   A61K   31/192   (20060101)   A61K   31/185   (20060101)  
USPTO Field of Search
424/448   424/449  
Related Patents
6506404 - Release of ibuprofen from hot melt adhesive compositions through addition of pharmaceutical auxiliaries - Owned by Beiersdorf AG (Hamburg,DE)

Use of auxiliaries to improve the release of ibuprofen from hot melt adhesive compositions.

5879702 - Analgesic anti-inflammatory adhesive preparations - Owned by Tokuhon Corporation (Tokyo,JP) Filed: January 6, 1998Related U.S. Patent DocumentsApplication NumberFiling DatePatent NumberIssue Date547336Oct., 19955776484

A non-steroidal analgesic anti-inflammatory adhesive preparation rendered by coating one surface of support with an adhesive containing S-(+)-2-(2-fluoro-4-biphenylyl)propionic acid and a styrene-isoprene-styrene block copolymer or S-(+)-2-(2-fluoro-4-biphenylyl) propionic acid and a modified copolymer in which methylmethacrylate is allowed to graft-polymerize on said copolymer, or with an adhesive containing S-(+)-2-(2-fluoro-4-biphenylyl) propionic acid, sodium carboxymethyl cellulose and sodium polyacrylate.

6676962 - Topical plaster with non-steroidal antirheumatic agents with an acid group - Owned by LTS Lohmann Therapie-Systeme (AG,DE)

A topical patch having non-steroid antirheumatic agent as active substance, consisting of a backing layer inert to the active substance, a self-adhesive, active substance-containing matrix layer based on a polyacrylate adhesive, and a protective film to be removed prior to use, is characterized in that a. the non-steroid antirheumatic agent has a free carboxyl group, b. the active substance-containing matrix of the patch consists of a polyacrylate adhesive cross-linked with multivalent metal ions and having free carboxyl groups, and is free of hydroxyl groups, c. the matrix contains a fatty acid as plasticizer and permeation enhancer, and d. the backing layer consists of a material that is elastic in at least one direction.

7256234 - Hybrid system for solubilizing pharmaceutically active substances in polymer matrices - Owned by Beiersdorf AG (Hamburg,DE)

The present invention is directed to a hybridized polymer matrix, a method of making such, and products incorporating such a matrix. The hybridized polymer matrix comprises a solvent-free polymer matrix base, a hybridized matrix comprising one or more poly(1-vinyl-2-pyrrolidones) and dimethyl sulfoxide, and at least one active substance. The hybridized polymer matrix is useful in the preparation of transdermal therapeutic systems, particularly making possible the introduction of pharmaceutically active substances which are otherwise difficult to dissolve, such as ibuprofen, into a non-polar matrix.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us